| Market Cap | ₹14,833Cr | 
| ROE | 15.93% | 
| P/E Ratio(TTM) | 65.72 | 
| EPS(TTM) | 27.57 | 
| P/B Ratio | 10.47 | 
| Dividend Yield | 0.08% | 
| Industry P/E | 40.62 | 
| Book Value | 173.03 | 
| Debt to Equity | 0.01 | 
| Face Value | 5 | 
| Parent Organisation | Acutaas Chemicals | 
| Managing Director | Mr. Nareshkumar Patel | 
| NSE Symbol | ACUTAAS | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%)  | 78.34  | ||
| Neuland Laboratories | NA (0.00%)  | 124.92  | ||
| Jubilant Pharmova | NA (0.00%)  | 39.26  | ||
| Gujarat Themis Biosyn | NA (0.00%)  | 113.44  |